NVCT insider trading
NasdaqCM HealthcareNuvectis Pharma, Inc.: insider trade history from SEC Form 4 filings.
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Company website: www.nuvectis.com
NVCT insider activity at a glance
FilingIQ tracks 187 insider transactions for NVCT in filings since Feb 8, 2022. The most recent transaction is dated Aug 3, 2026.
Across the full history, 153 open-market purchases
and 1 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest NVCT Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for NVCT?
- FilingIQ tracks 187 Form 4 insider transactions for NVCT (Nuvectis Pharma, Inc.), covering filings from Feb 8, 2022 onwards. 1 of those are dated within the last 90 days.
- Are NVCT insiders net buyers or net sellers?
- Across the full Form 4 history for NVCT, 153 transactions (82%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NVCT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is NVCT in?
- Nuvectis Pharma, Inc. (NVCT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $210.87M.
Methodology & sources
Every NVCT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.